JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Медицинская радиология и радиационная безопасность. 2025. Том 70. № 4
DOI:10.33266/1024-6177-2025-70-4-25-32
Е.А. Кодинцева1, А.А. Аклеев2
РОЛЬ КЛЕТОК-ЭФФЕКТОРОВ ВРОЖДЕННОГО И АДАПТИВНОГО ИММУНИТЕТА В ПАТОГЕНЕЗЕ РАДИАЦИОННО-ИНДУЦИРОВАННОГО КАНЦЕРОГЕНЕЗА. ОБЗОР (ЧАСТЬ 1)
1 Уральский научно-практический центр радиационной медицины ФМБА России, Челябинск
2 Южно-Уральский государственный медицинский университет Минздрава России, Челябинск
Контактное лицо: Екатерина Александровна Кодинцева, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
СОДЕРЖАНИЕ
Введение
1. Компоненты врожденного иммунитета и канцерогенез
2. Опухолеассоциированные клетки миелоидного происхождения и миелоидные супрессорные клетки
3. Опухолеассоциированные нейтрофилы
4. Опухолеассоциированные моноциты/макрофаги
5. Натуральные киллеры микроокружения злокачественных новообразований
6. Заключение
Ключевые слова: клетки периферической крови, радиационное воздействие, злокачественные новообразования, канцерогенез, врожденный иммунитет, адаптивный иммунитет, межклеточная кооперация, радиочувствительность
Для цитирования: Кодинцева Е.А., Аклеев А.А. Роль клеток-эффекторов врожденного и адаптивного иммунитета в патогенезе радиационно-индуцированного канцерогенеза. Обзор (часть 1) // Медицинская радиология и радиационная безопасность. 2025. Т. 70. № 4. С. 25–32. DOI:10.33266/1024-6177-2025-70-4-25-32
Список литературы
1. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-Related Inflammation. Nature. 2008;454;7203:436-444. doi: 10.1038/nature07205.
2. Weinstein I.B. Mitogenesis is Only One Factor in Carcinogenesis. Science. 1991;251; 4992:387-388. doi: 10.1126/science.1989073.
3. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR, 2006). Report to the General Assembly, with Scientific Annexes. V. 2. Annex C: Non-targeted and Delayed Effects of Exposure to Ionizing Radiation. New York, United Nations, 2008. 80 p.
4. Голивец Т.П., Коваленко Б.С., Волков Д.В. Актуальные аспекты радиационного канцерогенеза: проблема оценки эффектов воздействия «малых» доз ионизирующего излучения. Аналитический обзор // Научные ведомости Белгородского государственного университета. Медицина. Фармация». 2012. Т.19. №16. С. 5-13 [Golivets T.P., Kovalenko B.S., Volkov D.V. Current Aspects of Radiation Carcinogenesis: the Problem of Assessing the Effects of Exposure to «Small» Doses of Ionizing Radiation. Analytical Review. Nauchnyye Vedomosti Belgorodskogo Gosudarstvennogo Universiteta. Meditsina. Farmatsiya = Scientific Bulletin of the Belgorod State University. Medicine. Pharmacy. 2012;19;16:5-13 (In Russ.)].
5. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR 2020/2021). Report to the General Assembly, with Scientific Annexes: Sources, Effects and Risks of Ionizing Radiation. New York, United Nations, 2021. 244 р.
6. Аклеев А.В., Аклеев А.А., Андреев С.С., Блинова Е.А. и др. Последствия радиоактивного загрязнения реки Течи: Монография / Под ред. А.В.Аклеева. Челябинск: Книга, 2016. 400 c. [Akleyev A.V., Akleyev A.A., Andreyev S.S., Blinova Ye.A., et al. Posledstviya Radioaktivnogo Zagryazneniya Reki Techi = Consequences of Radioactive Contamination of the Techa River. Monograph. Ed.by A.V.Akleyev. Chelyabinsk, Kniga Publ., 2016. 400 p. (In Russ.)].
7. Крестинина Л.Ю., Силкин С.С., Микрюкова Л.Д., Епифанова С.Б., Аклеев А.В. Риск заболеваемости солидными злокачественными новообразованиями в Уральской когорте аварийно-облучённого населения: 1956-2017 // Радиационная гигиена. 2020. Т.13. №3. С. 6-17 [Krestinina L.Yu., Silkin S.S., Mikryukova L.D., Yepifanova S.B., Akleyev A.V. Risk of Solid Malignant Neoplasms in the Ural Cohort of the Accident-Exposed Population: 1956-2017. Radiatsionnaya Gigiyena = Radiation Hygiene. 2020;13;3:6-17 (In Russ.)]. doi: 10.21514/1998-426X-2020-13-3-6-17.
8. Туков А.Р., Шафранский И.Л., Котеров А.Н., Зиятдинов М.Н., Прохорова О.Н., Михайленко А.М. Оценка радиационного риска смерти от сердечно-сосудистых заболеваний ликвидаторов последствий аварии на ЧАЭС – работников предприятий атомной промышленности по данным о дозах различных видов облучения // Медицинская радиология и радиационная безопасность. 2024. Т.69. №3. С. 53-56 [Tukov A.R., Shafranskiy I.L., Koterov A.N., Ziyatdinov M.N., Prokhorova O.N., Mikhaylenko A.M. Assessment of the Radiation Risk of Death from Cardiovascular Diseases in Liquidators of the Consequences of the Chernobyl Accident - Workers of Nuclear Industry Enterprises Based on Data on Doses of Various Types of Radiation. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Medical Radiology and Radiation Safety. 2024;69;3:53-56 (In Russ.)]. doi:10.33266/1024-6177-2024-69-3-53-56.
9. Castelo-Branco C., Soveral I. The Immune System and Aging: a Review. Gynecological Endocrinology. 2013;30;1:16-22. doi: 10.3109/09513590.2013.852531.
10. Morrisette-Thomas V., Cohen A.A., Fülöp T., Riesco É., Legault V., Li Q., Milot E., Dusseault-Bélanger F., Ferrucci L. Inflamm-Aging does not Simply Reflect Increases in Pro-Inflammatory Markers. Mechanisms of Ageing and Development. 2014;139:49-57. doi: 10.1016/j.mad.2014.06.005.
11. Jackaman C., Tomay F., Duong L., Abdol Razak N.B., Pixley F.J., Metharom P., Nelson D.J. Aging and Cancer: the Role of Macrophages and Neutrophils. Ageing Research Reviews. 2017;36:105-116. doi: 10.1016/j.arr.2017.03.008.
12. Kim J.H., Brown S.L., Gordon M.N. Radiation-Induced Senescence: Therapeutic Opportunities. Radiation Oncology. 2023;18;10:1-11. doi:10.1186/s13014-022-02184-2.
13. Coffelt S.B., Kersten K., Doornebal C.W., Weiden J., Vrijland K., Hau C.S., Verstegen N.J.M., Ciampricotti M., Hawinkels L.J.A.C., Jonkers J., de Visser K.E. IL-17-Producing Gammadelta T Cells and Neutrophils Conspire to Promote Breast Cancer Metastasis. Nature. 2015;522:345-348. doi: 10.1038/nature14282.
14. Bronte V., Brandau S., Chen S.H. Colombo M.P., Frey A.B., Greten T.F., Mandruzzato S., Murray P.J., Ochoa A., Ostrand-Rosenberg S., Rodriguez P.C., Sica A., Umansky V., Vonderheide R.H., Gabrilovich D.I. Recommendations for Myeloid-Derived Suppressor Cell Nomenclature and Characterization Standards. Nature Communications. 2016;7:12150. doi: 10.1038/ncomms12150.
15. Патышева М.Р., Стахеева М.Н., Ларионова И.В., Тарабановская Н.А., Григорьева Е.С., Слонимская Е.М., Кжышковска Ю.Г., Чердынцева Н.В. Моноциты при злокачественных новообразованиях: перспективы и точки приложения для диагностики и терапии // Бюллетень сибирской медицины. 2019. Т.18. №1. C. 60-75 [Patysheva M.R., Stakheyeva M.N., Larionova I.V., Tarabanovskaya N.A., Grigor’yeva Ye.S., Slonimskaya Ye.M., Kzhyshkovska YU.G., Cherdyntseva N.V. Monocytes in Malignant Neoplasms: Prospects and Application Points for Diagnostics and Therapy. Byulleten’ Sibirskoy Meditsiny = Bulletin of Siberian Medicine. 2019;18;1:60-75 (In Russ.)]. doi: 10.20538/1682-0363-2019-1-60-75.
16. Strauss L., Sangaletti S., Consonni F.M., Szebeni G., Morlacchi S., Totaro M.G., Porta C., Anselmo A., Tartari S., Doni A., Zitelli F., Tripodo C., Colombo M.P., Sica A. RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis. Cancer Cell. 2015;28;2:253-269. doi: 10.1016/j.ccell.2015.07.006.
17. Pillay J., Kamp V.M., van Hoffen E., Visser T., Tak T., Lammers J.W., Ulfman L.H., Leenen L.P., Pickkers P., Koenderman L., Visser T., Tak T., Lammers J.W., Ulfman L.H., Leenen L.P., Pickkers P., Koenderman L. A Subset of Neutrophils in Human Systemic Inflammation Inhibits T Cell Responses Through MAC1. The Journal of Clinical Investigation. 2012;122;1:327-336. doi: 10.1172/JCI57990.
18. Brandau S., Dumitru C.A., Lang S. Protumor and Antitumor Functions of Neutrophil Granulocytes. Seminars in Immunopathology. 2013;35:163-176. doi: 10.1007/s00281-012-0344-6.
19. Fridlender Z.G., Sun J., Kim S. Kapoor V., Cheng G., Ling L., Worthen G.S., Albelda S.M. Polarization of Tumor-Associated Neutrophil Phenotype by TGF-Beta: N1 Versus N2 TAN. Cancer Cell. 2009;16;3:183-194. doi: 10.1016/j.ccr.2009.06.017.
20. Leliefeld P.H.C., Koenderman L., Pillay J. How Neutrophils Shape Adaptive Immune Responses. Frontiers in Immunology. 2015;6:471. doi: 10.3389/fimmu.2015.00471.
21. Batlle E., Massagué J. Transforming Growth Factor-β Signaling in Immunity and Cancer. Immunity. 2019;50;4:924-940. doi: 10.1016/j.immuni.2019.03.024.
22. Palano M.T., Gallazzi M., Cucchiara M., De Lerma Barbaro A., Gallo D., Bassani B., Bruno A., Mortara L. Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis.Vaccines. 2021;99;12:1488. doi: 10.3390/vaccines9121488.
23. Bonavita O., Massara M., Bonecchi R. Chemokine Regulation of Neutrophil Function in Tumors. Cytokine & Growth Factor Reviews. 2016;30:81-86. doi: 10.1016/j.cytogfr.2016.03.012.
24. Kitamura T., Fujishita T., Loetscher P., Revesz L., Hashida H., Kizaka-Kondoh S., Aoki M., Taketo M.M. Inactivation of Chemokine (C-C motif) Receptor 1 (CCR1) Suppresses Colon Cancer Liver Metastasis by Blocking Accumulation of Immature Myeloid Cells in a Mouse Model. The Proceedings of the National Academy of Sciences. 2010;107;29:13063-13068. doi: 10.1073/pnas.1002372107.
25. Yang L., Huang J., Ren X., Gorska A.E., Chytil A., Aakre M., Carbone D.P., Matrisian L.M., Richmond A., Lin P.C., Moses H.L. Abrogation of TGF Beta Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+. Myeloid Cells that Promote Metastasis. Cancer Cell. 2008;13:23-35. doi: 10.1016/j.ccr.2007.12.004.
26. Masucci M.T., Minopoli M., Del Vecchio S., Carriero M.V. The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis. Frontiers in Immunology. 2020;11:1749. doi: 10.3389/fimmu.2020.01749.
27. Albrengues J., Shields M.A., Ng D., Park C.G., Ambrico A., Poindexter M.E., Upadhyay P., Uyeminami D.L., Pommier A., Küttner V., Bružas E., Maiorino L., Bautista C., Carmona E.M., Gimotty P.A., Fearon D.T., Chang K., Lyons S.K., Pinkerton K.E., Trotman L.C., Goldberg M.S., Yeh J.T., Egeblad M. Neutrophil Extracellular Traps Produced during Inflammation Awaken Dormant Cancer Cells in Mice. Science. 2018;361;6409:eaao4227. doi: 10.1126/science.aao4227.
28. Grayson P.C., Carmona-Rivera C., Xu L., Lim N., Gao Z., Asare A.L., Specks U., Stone J.H., Seo P., Spiera R.F., Langford C.A., Hoffman G.S., Kallenberg C.G., St Clair E.W., Tchao N.K., Ytterberg S.R., Phippard D.J., Merkel P.A., Kaplan M.J., Monach P.A. Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated with Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatology. 2015;67:1922-1932. doi: 10.1002/art.39153.
29. Sagiv J.Y., Michaeli J., Assi S. Mishalian I., Kisos H., Levy L., Damti P., Lumbroso D., Polyansky L., Sionov R.V., Ariel A., Hovav A.H., Henke E., Fridlender Z.G., Granot Z. Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer. Cell Reports. 2015;10;4:562-573. doi: 10.1016/j.celrep.2014.12.039.
30. Mahiddine K., Blaisdell A., Ma S. Créquer-Grandhomme A., Lowell C.A., Erlebacher A. Relief of Tumor Hypoxia Unleashes the Tumoricidal Potential of Neutrophils. The Journal of Clinical Investigation. 2019;130;1:389-403. doi: 10.1172/JCI130952.
31. Campbell E.L. Hypoxia-Recruited Angiogenic Neutrophils. Blood. 2015;126;17: 1972-1973. doi: 10.1182/blood-2015-09-666578.
32. Powell D., Tauzin S., Hind L.E., Deng Q., Beebe D.J., Huttenlocher A. Chemokine Signaling and the Regulation of Bidirectional Leukocyte Migration in Interstitial Tissues. Cell Reports. 2017;19;8:1572-1585. doi: 10.1016/j.celrep.2017.04.078.
33. Vono M., Lin A., Norrby-Teglund A., Koup R.A., Liang F., Loré K. Neutrophils Acquire the Capacity for Antigen Presentation to Memory CD4(+) T Cells in vitro and ex vivo. Blood. 2017;129;14:1991-2001. doi: 10.1182/blood-2016-10-744441.
34. Puga I., Cols M., Barra C.M., He B., Cassis L., Gentile M., Comerma L., Chorny A., Shan M., Xu W., Magri G., Knowles D.M., Tam W., Chiu A., Bussel J.B., Serrano S., Lorente J.A., Bellosillo B., Lloreta J., Juanpere N., Alameda F., Baró T., de Heredia C.D., Torán N., Català A., Torrebadell M., Fortuny C., Cusí V., Carreras C., Diaz G.A., Blander J.M., Farber C.M., Silvestri G., Cunningham-Rundles C., Calvillo M., Dufour C., Notarangelo L.D., Lougaris V., Plebani A., Casanova J.L., Ganal S.C., Diefenbach A., Aróstegui J.I., Juan M., Yagüe J., Mahlaoui N., Donadieu J., Chen K., Cerutti A. B Cell-Helper Neutrophils Stimulate the Diversification and Production of Immunoglobulin in the Marginal Zone of the Spleen. Nature Immunology. 2011;13:170-180. doi: 10.1038/ni.2194.
35. Metzemaekers M., Gouwy M., Proost P. Neutrophil Chemoattractant Receptors in Health and Disease: Double-Edged Swords. Cellular & Molecular Immunology. 2020;17:433-450. doi: 10.1038/s41423-020-0412-0.
36. Fine N., Tasevski N., McCulloch C.A., Tenenbaum H.C., Glogauer M. The Neutrophil: Constant Defender and First Responder. Frontiers in Immunology. 2020;11:571085. doi: 10.3389/fimmu.2020.571085.
37. Evrard M., Kwok I.W.H., Chong S.Z., Teng K.W.W., Becht E., Chen J., Sieow J.L., Penny H.L., Ching G.C., Devi S., Adrover J.M., Li J.L.Y., Liong K.H., Tan L., Poon Z., Foo S., Chua J.W., Su I.H., Balabanian K., Bachelerie F., Biswas S.K., Larbi A., Hwang W.Y.K., Madan V., Koeffler H.P., Wong S.C., Newell E.W., Hidalgo A., Ginhoux F., Ng L.G. Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, Effector Functions. Immunity. 2018;48;2:364-379.e8. doi: 10.1016/j.immuni.2018.02.002.
38. Zhu Y.P., Padgett L., Dinh H.Q., Marcovecchio P., Blatchley A., Wu R., Ehinger E., Kim C., Mikulski Z., Seumois G., Madrigal A., Vijayanand P., Hedrick C.C. Identification of an Early Unipotent Neutrophil Progenitor with Pro-Tumoral Activity in Mouse and Human Bone Marrow. Cell Reports. 2018;24;9:2329-2341. doi: 10.1016/j.celrep.2018.07.097.
39. Zhang D., Chen G., Manwani D., Mortha A., Xu C., Faith J.J., Burk R.D., Kunisaki Y., Jang J.E., Scheiermann C., Merad M., Frenette P.S. Neutrophil Ageing is Regulated by the Microbiome. Nature. 2015;525:528-532. doi: 10.1038/nature15367.
40. Szebeni G.J., Vizler C., Kitajka K., Puskas L.G. Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters. Mediators Inflammation. 2017:9294018. doi: 10.1155/2017/9294018.
41. Грачев А.Н., Самойлова Д.В., Рашидова М.А., Петренко А.А., Ковалева О.В. Макрофаги, ассоциированные с опухолью: современное состояние исследований и перспективы клинического использования // Успехи молекулярной онкологии. 2018. Т.5. №4. C. 20-28 [Grachev A.N., Samoylova D.V., Rashidova M.A., Petrenko A.A., Kovaleva O.V. Tumor-Associated Macrophages: Current State of Research and Prospects for Clinical Use. Uspekhi Molekulyarnoy Onkologii = Advances in Molecular Oncology. 2018;5;4:20-28 (In Russ.)]. doi: 10.17650/2313-805X-2018-5-4-20-28.
42. Becherini C., Lancia A., Detti B., Lucidi S., Scartoni D., Ingrosso G., Carnevale M.G., Roghi M., Bertini N., Orsatti C., Mangoni M., Francolini G., Marani S., Giacomelli I., Loi M., Pergolizzi S., Bonzano E., Aristei C., Livi L. Modulation of Tumor-Associated Macrophage Activity with Radiation Therapy: a Systematic Review. Strahlentherapie und Onkologie. 2023;199:1173-1190. doi: 10.1007/s00066-023-02097-3.
43. Kelly A., Gunaltay S., McEntee C.P., Shuttleworth E.E., Smedley C., Houston S.A., Fenton T.M., Levison S., Mann E.R., Travis M.A. Human Monocytes and Macrophages Regulate Immune Tolerance Via Integrin αvβ8-Mediated TGFβ Activation. Journal of Experimental Medicine. 2018;215;11:2725-2736. doi: 10.1084/jem.20171491.
44. Arwert E.N., Harney A.S., Entenberg D., Wang Y., Sahai E., Pollard J.W., Condeelis J.S. A Unidirectional Transition from Migratory to Perivascular Macrophage is Required for Tumor Cell Intravasation. Cell Reports. 2018;23:1239-1248. doi: 10.1016/j.celrep.2018.04.007.
45. Bron S., Henry L., Faes-Van’t Hull E., Turrini R., Vanhecke D., Guex N., Ifticene-Treboux A., Marina Iancu E., Semilietof A., Rufer N., Lehr H.A., Xenarios I., Coukos G., Delaloye J.F., Doucey M.A. TIE-2-Expressing Monocytes are Lymphangiogenic and Associate Specifically with Lymphatics of Human Breast Cancer. Oncoimmunology. 2016;5;2:e1073882. doi: 10.1080/2162402X.2015.1073882.
46. Guilliams M., van de Laar L. A Hitchhiker’s Guide to Myeloid Cell Subsets: Practical Implementation of a Novel Mononuclear Phagocyte Classification System. Frontiers in Immunology. 2015;6:406. doi: 10.3389/fimmu.2015.00406.
47. Чердынцева Н.В., Митрофанова И.В., Булдаков М.А., Стахеева М.Н., Патышева М.Р., Завьялова М.В., Кжышковска Ю.Г. Макрофаги и опухолевая прогрессия: на пути к макрофаг-специфичной терапии // Бюллетень сибирской медицины. 2017. Т.16. №4. C. 61-74 [Cherdyntseva N.V., Mitrofanova I.V., Buldakov M.A., Stakheyeva M.N., Patysheva M.R., Zav’yalova M.V., Kzhyshkovskaya Yu.G. Macrophages and Tumor Progression: Towards Macrophage-Specific Therapy. Byulleten’ Sibirskoy Meditsiny = Bulletin of Siberian Medicine. 2017;16;4:61-74 (In Russ.)]. doi: 10.20538/1682-0363-2017-4-61-74.
48. Wynn T.A., Chawla A., Pollard J.W. Macrophage Biology in Development, Homeostasis and Disease. Nature. 2013;496:445-455. doi: 10.1038/nature12034.
49. Sierra J.M., Secchiari F., Nunez S.Y., Iraolagoitia X.L.R., Ziblat A., Friedrich A.D., Regge M.V., Santilli M.C., Torres N.I., Gantov M., Trotta A., Ameri C., Vitagliano G., Pita H.R., Rico L., Rovegno A., Richards N., Domaica C.I., Zwirner N.W., Fuertes M.B. Tumor-Experienced Нuman NK Cells Express High Levels of PD-L1 and Inhibit CD8(+) T Cell Proliferation. Frontiers in Immunology. 2021;12:745939. doi: 10.3389/fimmu.2021.745939.
50. Stojanovic A., Cerwenka A. Natural Killer Cells and Solid Tumors. Journal of Innate Immunity. 2011;3;4:355-364. doi: 10.1159/000325465.
51. Habif G., Crinier A., Andre P., Vivier E., Narni-Mancinelli E. Targeting Natural Killer Cells in Solid Tumors. Cellular & Molecular Immunology. 2019;16:415-422. doi: 10.1038/s41423-019-0224-2.
52. Levi I., Amsalem H., Nissan A., Darash-Yahana M., Peretz T., Mandelboim O., Rachmilewitz J. Characterization of Tumor Infiltrating Natural Killer Cell Subset. Oncotarget. 2015;6:13835-13843. doi: 10.18632/oncotarget.3453.
53. Cózar B., Greppi M., Carpentier S., Narni-Mancinelli E., Chiossone L., Vivier E. Tumor-Infiltrating Natural Killer Cells. Cancer Discovery. 2021;11:34-44. doi: 10.1158/2159-8290.CD-20-0655.
54. Gallazzi M., Baci D., Mortara L., Bosi A., Buono G., Naselli A., Guarneri A., Dehò F., Capogrosso P., Albini A., Noonan D.M., Bruno A. Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors. Frontiers in Immunology. 2020;11:586126. doi: 10.3389/fimmu.2020.586126.
55. Bruno A., Bassani B., D’Urso D.G., Pitaku I., Cassinotti E., Pelosi G., Boni L., Dominioni L., Noonan D.M., Mortara L., Albini A. Angiogenin and the MMP9-TIMP2 Axis are Up-Regulated in Proangiogenic, Decidual NK-Like Cells from Patients with Colorectal Cancer. Federation of American Societies for Experimental Biology Journal. 2018;32:5365-5377. doi: 10.1096/fj.201701103R.
56. Gotthardt D., Putz E.M., Grundschober E., Prchal-Murphy M., Straka E., Kudweis P., Heller G., Bago-Horvath Z., Witalisz-Siepracka A., Cumaraswamy A.A., Gunning P.T., Strobl B., Müller M., Moriggl R., Stockmann C., Sexl V. STAT5 is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion. Cancer Discovery. 2016;6:414-429. doi: 10.1158/2159-8290.CD-15-0732.
57. Корнева Е.А. Пути взаимодействия нервной и иммунной систем: история и современность, клиническое применение // Медицинская иммунология. 2020. Т. 22. №3. С. 405-418 [Korneva Ye.A. Pathways of Interaction between the Nervous and Immune Systems: History and Modernity, Clinical Application. Meditsinskaya Immunologiya = Medical Immunology. 2020;22;3:405-418 (In Russ.)]. doi: 10.15789/1563-0625-PON-1974.
58. Stakheyeva M., Eidenzon D., Slonimskaya E., Patysheva M., Bogdashin I., Kolegova E., Grigoriev E., Choinzonov E., Cherdyntseva N. Integral Characteristic of the Immune System State Predicts Breast Cancer Outcome. Experimental Oncology. 2019;41;1:32-38.
PDF (RUS) Полная версия статьи
Конфликт интересов. Авторы заявляют об отсутствии конфликта интересов.
Финансирование. Научно-исследовательская работа выполнена в рамках государственного задания ФМБА России по теме «Исследование функционального состояния клеток-эффекторов противоопухолевого иммунитета человека в период реализации канцерогенных эффектов хронического радиационного воздействия» (Соглашение о предоставлении субсидии из федерального бюджета на финансовое обеспечение выполнения государственного задания на оказание государственных услуг (выполнение работ) № 388-03-2025-085 от 24 января 2025 года).
Участие авторов. Все авторы подтверждают соответствие своего авторства международным критериям ICMJE. Кодинцева Е.А. – разработала концепцию статьи, подготовила первый вариант документа, прочитала и согласовала последний вариант рукописи. Аклеев А.А. – разработал концепцию статьи, выполнил научное редактирование, прочитал и утвердил последний вариант рукописи.
Поступила: 20.03.2025. Принята к публикации: 25.04.2025.